Saketh R. Guntupalli

University of Colorado Denver, University of Colorado System

Papers

6

Total Citations

244

H-Index

5

About

Saketh R. Guntupalli is a leading gynecologic oncologist whose research focuses on improving surgical outcomes and thromboprophylaxis for women with gynecologic malignancies. His most impactful work, a 2020 study on apixaban versus enoxaparin for preventing venous thromboembolism after gynecologic cancer surgery (133 citations), challenges standard 28-day enoxaparin regimens by demonstrating the safety and efficacy of a more convenient, cost-effective alternative—a finding with direct implications for patient adherence and healthcare costs. Dr. Guntupalli has also made significant contributions to the field of robotic surgery for endometrial cancer, authoring multiple high-impact papers (45, 24, and 21 citations) that compare outcomes between robotic and laparotomic staging, particularly in older patients aged 65 and above. His work consistently explores disparities in surgical access and the nuances of minimally invasive techniques, including the role of lymphovascular space invasion (17 citations). With a career dedicated to evidence-based practice, Dr. Guntupalli’s research has shaped clinical guidelines and improved the quality of care for women facing complex gynecologic cancers.

Research Focus

Key Achievements

5
H-Index
6
Papers
244
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm
133 citations · 2020
📈 Most Prolific Year: 2015 (2 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: University of Colorado Denver, University of Colorado System

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago